CD31 in carcinomas and mesotheliomas1

salivary gland

mucoepidermoid

2/5

acinic cell

0/2

adenoid cystic

0/4

carcinoma ex pleomorphic adenoma

0/1

skin

squamous cell

1/26

basal cell

0/9

adnexal

1/6

thyroid

papillary

2/25

follicular

0/11

medullary

0/1

pulmonary

adenocarcinoma

0/23

squamous cell carcinoma

0/5

small cell carcinoma

0/3

mesothelioma

0/9

nasopharyngeal and laryngeal

squamous cell carcinoma

0/9

kidney

renal cell carcinoma

0/9

transitional cell carcinoma

0/4

prostate

0/16

gastrointestinal

1/27

liver

hepatocellular carcinoma

0/13

gallbladder

adenocarcinoma

0/6

adrenal

adrenal cortical carcinoma

0/2

endometrial

adenocarcinoma

0/8

ovarian

 carcinoma

0/5

cervical

squamous cell carcinoma

0/3

all sites

sarcomatoid carcinoma

0/9

References

1De Young, B. R., H. F. Frierson, et al. (1998). "CD31 immunoreactivity in carcinomas and mesotheliomas." Am J Clin Pathol 110(3): 374-7.

This page last revised 17.3.2001.

©SMUHT/PW Bishop